Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) Net Income towards Common Stockholders (2016 - 2025)

cbdMD's Net Income towards Common Stockholders history spans 10 years, with the latest figure at -$324602.0 for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 67.06% year-over-year to -$324602.0; the TTM value through Dec 2025 reached -$3.7 million, up 44.5%, while the annual FY2025 figure was -$4.4 million, 43.21% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was -$324602.0 at cbdMD, up from -$679968.0 in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $977007.0 in Q2 2021 and bottomed at -$32.6 million in Q2 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$2.6 million (2023), against an average of -$6.5 million.
  • The largest annual shift saw Net Income towards Common Stockholders surged 110.91% in 2021 before it plummeted 3440.27% in 2022.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$20.2 million in 2021, then surged by 75.42% to -$5.0 million in 2022, then surged by 59.71% to -$2.0 million in 2023, then soared by 50.66% to -$985406.0 in 2024, then soared by 67.06% to -$324602.0 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Net Income towards Common Stockholders are -$324602.0 (Q4 2025), -$679968.0 (Q3 2025), and -$1.2 million (Q2 2025).